Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 2, 2008, Pages 320-329

  Shin, Aesun ^a,f   Shrubsole, Martha J ^a,b,c   Rice, Jeffrey M ^d   Cai, Qiuyin ^a,c   Doll, Mark A ^d   Long, Jirong ^a,c   Smalley, Walter E ^a,b,c   Shyr, Yu ^c   Sinha, Rashmi ^e   Ness, Reid M ^a,b,c   Hein, David W ^d   Zheng, Wei ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Education and Clinical Center   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d University of Louisville School of Medicine   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AROMATIC HYDROCARBON RECEPTOR; ARYLAMINE ACETYLTRANSFERASE; CARCINOGEN; CYTOCHROME P450 1A2; HETEROCYCLIC AMINE; N ACETYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ADENOMA; ADULT; AGED; ARTICLE; CARCINOGENESIS; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERPLASIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEAT; PRIORITY JOURNAL; PROTEIN FUNCTION; RECTUM POLYP; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ACETYLTRANSFERASES; ADULT; AGED; CHI-SQUARE DISTRIBUTION; COLONIC POLYPS; COLONOSCOPY; CYTOCHROME P-450 ENZYME SYSTEM; GENOTYPE; HUMANS; MEAT; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, ARYL HYDROCARBON; RISK FACTORS; TENNESSEE;

EID: 39449127911     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0615     Document Type: Article

References (52)

1. Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 2002;98:241-56.
2. Sinha R, Cross A, Curtin J, et al. Development of a food frequency questionnaire module and databases for compounds in cooked and processed meats. Mol Nutr Food Res 2005;49:648-55.
3. Vineis P, McMichael A. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer. Cancer Causes Control 1996;7:479-86.
4. Nowell SA, Ahn J, Ambrosone CB. Gene-nutrient interactions in cancer etiology. Nutr Rev 2004;62:427-38.
5. Fujii-Kuriyama Y, Mimura J. Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem Biophys Res Commun 2005;338:311-7.
6. Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991;12:1839-45.
7. Brockton N, Little J, Sharp L, Cotton SC. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000;151:846-61.
8. Le Marchand L, Hankin JH, Pierce LM, et al. Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutat Res 2002;506-507:205-14.
9. Anderson WF, Guyton KZ, Hiatt RA, Vernon SW, Levin B, Hawk E. Colorectal cancer screening for persons at average risk. J Natl Cancer Inst 2002;94:1126-33.
10. Gunter MJ, Probst-Hensch NM, Cortessis VK, Kulldorff M, Haile RW, Sinha R. Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case-control study. Carcinogenesis 2005;26:637-42.
11. Sinha R, Peters U, Cross AJ, et al. Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res 2005;65:8034-41.
12. Yoon H, Benamouzig R, Little J, Francois-Collange M, Tome D. Systematic review of epidemiological studies on meat, dairy products and egg consumption and risk of colorectal adenomas. Eur J Cancer Prev 2000;9:151-64.
13. Mathew A, Sinha R, Burt R, et al. Meat intake and the recurrence of colorectal adenomas. Eur J Cancer Prev 2004;13:159-64.
14. Robertson DJ, Sandler RS, Haile R, et al. Fat, fiber, meat and the risk of colorectal adenomas. Am J Gastroenterol 2005;100:2789-95.
15. Ishibe N, Sinha R, Hein DW, et al. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Pharmacogenetics 2002;12:145-50.
16. Probst-Hensch NM, Haile RW, Li DS, et al. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis 1996;17:2125-9.
17. Roberts-Thomson IC, Ryan P, Khoo KK, Hart WJ, McMichael AJ, Butler RN. Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 1996;347:1372-4.
18. Tiemersma EW, Voskuil DW, Bunschoten A, et al. Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population. Cancer Causes Control 2004;15:225-36.
19. Huang CS, O'Brien MJ, Yang S, Farraye FA. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am J Gastroenterol 2004;99:2242-55.
20. Goode EL, Potter JD, Bamlet WR, Rider DN, Bigler J. Inherited variation in carcinogen-metabolizing enzymes and risk of colorectal polyps. Carcinogenesis 2007;28:328-41.
21. Buchowski MS, Schlundt DG, Hargreaves MK, Hankin JH, Signorello LB, Blot WJ. Development of a culturally sensitive food frequency questionnaire for use in the Southern Community Cohort Study. Cell Mol Biol 2003;49:1295-304.
22. Shin A, Shrubsole MJ, Ness RM, et al. Meat and meat-mutagen intake, doneness preference and the risk of colorectal polyps: the Tennessee Colorectal Polyp Study. Int J Cancer 2007;121:2890-6.
23. Doll MA, Hein DW. Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1. Anal Biochem 2002;301:328-32.
24. Hein DW. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 2006;25:1649-58.
25. Zhu Y, Hein DW. Functional effects of single nucleotide polymorphisms in the coding region of N-acetyltransferase 1. Pharmacogenomics J 2007 Oct 2 [Epub ahead of print].
26. Hein DW, McQueen CA, Grant DM, Goodfellow GH, Kadlubar FF and Weber WW. Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber. Drug Metab Dispos 2000;2812:1425-32.
27. Chen J, Stampfer MJ, Hough HL, et al. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 1998;58:3307-11.
28. Kampman E, Slattery ML, Bigler J, et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study. Cancer Epidemiol Biomarkers Prev 1999;8:15-24.
29. Lilla C, Verla-Tebit E, Risch A, et al. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 2006;15:99-107.
30. Fretland AJ, Leff MA, Doll MA, Hein DW. Functional characterization of human N acetyltransferase 2 (NAT2) single nucleotide polymorphisms. Pharmacogenetics 2001;11:207-15.
31. Hickman D, Pope J, Patil SD, et al. Expression of arylamine N-acetyltransferase in human intestine. Gut 1998;42:402-9.
32. Hein DW, Fretland AJ, Doll MA. Effects of single nucleotide polymorphisms in human N-acetyltransferase 2 on metabolic activation (O-acetylation) of heterocyclic amine carcinogens. Int J Cancer 2006;119:1208-11.
33. Purewal M, Velasco M, Fretland AJ, Hein DW, Wargovich MJ. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats. Cancer Epidemiol Biomarkers Prev 2000;9:529-32.
34. Nerurkar PV, Schut HA, Anderson LM, et al. DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in colon, bladder, and kidney of congenic mice differing in Ah responsiveness and N-acetyltransferase genotype. Cancer Res 1995;55:3043-9.
35. Sachse C, Bhambra U, Smith G, et al. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 2003;55:68-76.
36. Rasmussen BB, Brix TH, Kyvik KO, Brosen K. The interindividual differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 2002;12:473-8.
37. Moonen H, Engels L, Kleinjans J, Kok T. The CYP1A2-164A->C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans. Cancer Lett 2005;229:25-31.
38. Pavanello S, Pulliero A, Lupi S, Gregorio P, Clonfero E. Influence of the genetic polymorphism in the 5′-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers. Mutat Res 2005;587:59-66.
39. Long JR, Egan KM, Dunning L, et al. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics 2006;16:237-43.
40. Nordmark A, Lundgren S, Ask B, Granath F, Rane A. The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women. Br J Clin Pharmacol 2002;54:504-10.
41. Bae SY, Choi SK, Kim KR, et al. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci 2006;97:774-9.
42. Harper PA, Wong JY, Lam MS, Okey AB. Polymorphisms in the human AH receptor. Chem Biol Interact 2002;141:161-87.
43. Chen Y, Bai Y, Yuan J, et al. Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers. Cancer Epidemiol Biomarkers Prev 2006;15:1703-7.
44. Erhardt JG, Kreichgauer HP, Meisner C, Bode JC, Bode C. Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps - a case control study. Eur J Nutr 2002;41:35-43.
45. Potter JD, Bigler J, Fosdick L, et al. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms. Cancer Epidemiol Biomarkers Prev 1999;8:69-75.
46. Hawkins NJ, Ward RL. Sporadic colorectal cancers with micro-satellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 2001;93:1307-13.
47. Diergaarde B, Braam H, van Muijen GN, Ligtenberg MJ, Kok FJ, Kampman E. Dietary factors and microsatellite instability in sporadic colon carcinomas. Cancer Epidemiol Biomarkers Prev 2003;12:1130-6.
48. Luchtenborg M, Weijenberg MP, de Goeij AF, et al. Meat and fish consumption, APC gene mutations and hMLH1 expression in colon and rectal cancer: a prospective cohort study (The Netherlands). Cancer Causes Control 2005;16:1041-54.
49. Slattery ML, Anderson K, Curtin K, Ma KN, Schaffer D, Samowitz W. Dietary intake and microsatellite instability in colon tumors. Int J Cancer 2001;93:601-7.
50. Wu AH, Shibata D, Yu MC, Lai MY, Ross RK. Dietary heterocyclic amines and microsatellite instability in colon adenocarcinomas. Carcinogenesis 2001;22:1681-4.
51. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006;3012:1491-501.
52. Brennan P. Commentary: Mendelian randomization and gene-environment interaction. Int J Epidemiol 2004;33:17-21.